Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy

PURPOSE: Thymic malignancies, comprising thymoma and thymic carcinoma, are rare. Consequently, optimal chemotherapy for advanced thymic malignancies remains controversial. Platinum-based chemotherapy is currently the consensus treatment based on the results of single-arm phase II trials and retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuma, Yusuke, Saito, Makoto, Hosomi, Yukio, Sakuyama, Toshikazu, Okamura, Tatsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293490/
https://www.ncbi.nlm.nih.gov/pubmed/25146529
http://dx.doi.org/10.1007/s00432-014-1800-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293490/
https://www.ncbi.nlm.nih.gov/pubmed/25146529
http://dx.doi.org/10.1007/s00432-014-1800-6

Ejemplares similares